Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Borgwardt

Showing results (1-10 of 387) with videos related to

Pageof 39
Sort By:
Current Pharmaceutical Design|June 22, 2012
Cannabis and psychosis: targeting potential treatmentsStefan Borgwardt
Fortschritte Der Neurologie-Psychiatrie|April 7, 2026
[Routine clinical data and innovative therapeutic approaches - implications for the further development of psychiatry and neuropsychiatry]Stefan Borgwardt
Current Topics in Medicinal Chemistry|January 3, 2013
Editorial: neurochemistry of schizophrenia and psychosis: the contribution of neuroimagingStefan Borgwardt
Frontiers in Psychiatry|October 28, 2016
Editorial: Third-Generation Neuroimaging: Translating Research into Clinical UtilityAndré Schmidt, Stefan Borgwardt
Current Medicinal Chemistry|November 20, 2012
Molecular bases of antipsychotic drugs: the contribution of neurosciencesStefan Borgwardt, Andre Schmidt
Cell Reports. Medicine|September 17, 2025
Psychedelics for major depression-From controlled research settings into broader clinical useMihai Avram, Stefan Borgwardt
Neuroimage|May 21, 2013
Abnormal effective connectivity in the psychosis high-risk stateAndré Schmidt, Stefan Borgwardt
Psychological Medicine|July 19, 2013
Multifaceted impairments of impulsivity in cannabis users?Johannes Wrege, Stefan Borgwardt
Medical Hypotheses|August 9, 2007
Apoptosis may be the main cause for acceleration of normal changes in adolescent brain structure, leading to the onset of psychosisMurat Yildiz, Stefan Borgwardt
The British Journal of Psychiatry : the Journal of Mental Science|October 4, 2017
Implementing magnetic resonance imaging into clinical routine screening in patients with psychosis?Stefan Borgwardt, André Schmidt
Pageof 39

Showing results (1-10 of 387) with videos related to

Sort By:
Pageof 39
Current Pharmaceutical Design|June 22, 2012
Cannabis and psychosis: targeting potential treatmentsStefan Borgwardt
Fortschritte Der Neurologie-Psychiatrie|April 7, 2026
[Routine clinical data and innovative therapeutic approaches - implications for the further development of psychiatry and neuropsychiatry]Stefan Borgwardt
Current Topics in Medicinal Chemistry|January 3, 2013
Editorial: neurochemistry of schizophrenia and psychosis: the contribution of neuroimagingStefan Borgwardt
Frontiers in Psychiatry|October 28, 2016
Editorial: Third-Generation Neuroimaging: Translating Research into Clinical UtilityAndré Schmidt, Stefan Borgwardt
Current Medicinal Chemistry|November 20, 2012
Molecular bases of antipsychotic drugs: the contribution of neurosciencesStefan Borgwardt, Andre Schmidt
Cell Reports. Medicine|September 17, 2025
Psychedelics for major depression-From controlled research settings into broader clinical useMihai Avram, Stefan Borgwardt
Neuroimage|May 21, 2013
Abnormal effective connectivity in the psychosis high-risk stateAndré Schmidt, Stefan Borgwardt
Psychological Medicine|July 19, 2013
Multifaceted impairments of impulsivity in cannabis users?Johannes Wrege, Stefan Borgwardt
Medical Hypotheses|August 9, 2007
Apoptosis may be the main cause for acceleration of normal changes in adolescent brain structure, leading to the onset of psychosisMurat Yildiz, Stefan Borgwardt
The British Journal of Psychiatry : the Journal of Mental Science|October 4, 2017
Implementing magnetic resonance imaging into clinical routine screening in patients with psychosis?Stefan Borgwardt, André Schmidt
Pageof 39